Europe PMC
open access
Association between the EU desflurane phase-out and secondary market vaporizer prices: An observational time-series analysis
Background The European Union restricted desflurane-the volatile anesthetic with the highest commonly reported 100-year global warming potential (GWP100 ≈ 2540 CO₂ equivalents)-for routine use from 1 January 2026 under Regulation (EU) 2024/573, with exemptions for clinically necessary cases.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Electricity prices components for household consumers - annual data (from 2007 onwards)#796187
- Evaluating energy security of the European Union and overcoming current challenges#750582
- 42 CFR Part 10 — 340B Drug Pricing Program#509880
- Energy and climate security priorities and challenges in the changing global energy order#954990
- Bicarbonate Variation Monitoring With Indirect Calorimetry#862822
Record · ID 970726
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive